Fomitopsis pinicola

Fomitopsis pinicola (Red-Belted Conk): A Comprehensive Reference

1. Identity, Taxonomy, and Morphology

Scientific Nomenclature and Synonymy

Fomitopsis pinicola (Schwartz: Fr.) Karst., commonly known as the red-belted conk, is a widespread species of brown-rot fungus found throughout the Northern Hemisphere. Its accepted binomial is Fomitopsis pinicola (Sw.) P. Karst., with recognized synonyms including Fomes marginatus (Pers.) Fr. and Fomes pinicola (Sw.) Fr., and it belongs to the family Fomitopsidaceae. Other common names in use include the red-belted bracket fungus. Numerous local names exist for F. pinicola, including the Japanese name Tsugasaruno-koshikake and the English name red-belted bracket fungus.

Taxonomic Position

Fomitopsis is a genus of more than 40 species of bracket fungi in the family Fomitopsidaceae; the genus was circumscribed by Finnish mycologist Petter Karsten in 1881, with Fomitopsis pinicola as the type species. Molecular analysis indicates that Fomitopsis belongs to the antrodia clade, which contains about 70 percent of brown-rot fungi. Fomitopsis pinicola is commonly known as a brown-rot fungus, characterised by bipolar sexual compatibility and the presence of the phenol oxidase tyrosinase, with extracellular oxidase not present.

Species Complex and Taxonomic Caution

Fomitopsis pinicola has been recognized as a species complex comprising morphologically cryptic taxa that were historically lumped together due to their close similarities in macroscopic and microscopic features, as well as overlapping ecological niches on coniferous and deciduous hosts. These similarities, including comparable basidiocarp coloration, pore structure, and brown-rot decay patterns, contributed to the long-standing treatment of diverse populations as a single species across the Northern Hemisphere. Recent studies show that it is a species complex; three species from North America and one species from Europe have been recognized in this complex. In the current study, six new species in the Fomitopsis pinicola complex were discovered from East Asia, based on morphological characters and phylogenetic analyses inferred from the sequence data of the internal transcribed spacer (ITS) regions, the second subunit of RNA polymerase II (RPB2), and the translation elongation factor 1-α gene (TEF). This taxonomic complexity has direct implications for medicinal research: only studies wherein fungal specimens were sourced from Europe or Asia should be treated as referring to authentic F. pinicola, as samples identified as F. pinicola from North America were probably not F. pinicola, but a different species.

Morphology and Natural Source

Fomitopsis pinicola is a perennial bracket fungus belonging to the family Fomitopsidaceae, recognized for its woody, hoof-shaped fruitbodies that feature a varnished upper surface transitioning from orange-red to dark brownish-red with concentric zones, and a pale whitish to yellowish pore surface beneath. It grows solitarily or in overlapping clusters on the deadwood of conifers and hardwoods, occasionally parasitizing living trees, and is widespread in temperate forests across Eurasia, where it plays a key role as a wood decomposer causing brown cubical rot.

The fruiting body is fan shaped, has a hard, woody texture, can grow up to 40 cm in diameter, and is often referred to as the red belt conk. The fruiting body has a glossy appearance and can be red-brown or a lighter colour depending on the age of the specimen.

Fomitopsis pinicola associates with 83 softwood and 42 hardwood species, exhibiting broad ecological adaptability. It is a wood-colonising saprotroph and tree pathogen, causing severe brown rot–type wood degradation, and grows on both live and dead coniferous and deciduous trees, especially Picea, Alnus, and Fagus species.

Common Forms and Preparations

It is used as a medicinal mushroom in Asia, and is reported to provide health, nutritional, and therapeutic benefits due to its antimicrobial, anti-inflammatory, and antitumor activities. F. pinicola is now being marketed as a tea and food supplement. Fruiting body preparations include hot water extracts (decoctions), ethanolic and methanolic extracts, chloroform extracts used in research, and powders derived from dried fruiting bodies. The mycelium and its submerged-fermentation broth are also sources of bioactive material used in research contexts. Homeopathic preparations registered in the United States, such as "Pleo Pin," use Fomitopsis pinicola e mycelio at diluted potencies (e.g., 5X) in a base of purified water. Capsule homeopathic formulations contain 330 mg of Fomitopsis pinicola e mycelio at a 4X potency in a lactose base.

2. Traditional and Historical Use

European Folk Medicine

Five polypore species, including Fomitopsis pinicola, have been widely used in central European folk medicines for the treatment of various diseases, including dysmenorrhoea, haemorrhoids, bladder disorders, pyretic diseases, treatment of coughs, cancer, and rheumatism. Prehistoric artefacts going back over 5000 years underline the long tradition of using polypores for various applications ranging from food or tinder material to medicinal-spiritual uses, as witnessed by two polypore species found among items of Ötzi, the Iceman.

In traditional medicine, Fomitopsis pinicola was used for the treatment of headache, nausea, and liver problems. Moreover, due to their astringent effects, the fruit bodies have been used as haemostatics and anti-inflammatory agents. It has also been used as a hemostyptic and as tinder.

Chinese and Korean Traditional Medicine

Fomitopsis pinicola is a well-known medicinal mushroom that has been used for many years in traditional Chinese medicine and Korean folk medicine. It has been used in Chinese and Korean traditional folk medicine as an anti-inflammatory agent and for general well-being. In Korean folk medicine, it has been used to treat diabetes. In Northeast China, it has also been traditionally used to treat poor leg circulation in the elderly.

Japanese Folk Use

F. pinicola was traditionally used as a health food source for plant growth regulation and diabetes in Japan.

Cross-Cultural Traditional Preparations

The Red-belted Conk is a polypore fungus notable for its medicinal applications and ecological versatility. Historically used by indigenous peoples for medicinal purposes, it serves as a purgative and emetic, with modern herbalists utilizing its extracts for gastrointestinal health and skin care. In the traditional medicine of many countries, F. pinicola was used to treat headache, nausea, inflammation, and liver problems. Some homeopathic pharmacopeias (e.g., HAB 34, HPUS 92) contain monographs about F. pinicola.

3. Key Constituents and Active Compounds

Primary Chemical Classes

Chemical compounds found in F. pinicola include steroids, sesquiterpenes, lanostane triterpenoids, and triterpene glycosides. F. pinicola has been extensively studied for its bioactive compounds, especially its phenolic acids, triterpenoids, and polysaccharides, which have antimicrobial, antioxidant, and therapeutic properties.

Over the past decade, approximately 150 compounds, predominantly lanostane-triterpenoids, have been isolated from F. pinicola, with 18 compounds evaluated for their antimicrobial activity. Additional classes of bioactive constituents, including phenolic compounds, polysaccharides, and fatty acids, further contribute to its broad-spectrum antimicrobial potential.

Triterpenoids

Two new lanostane triterpenoids and 10 new lanostane triterpene glycosides have been isolated from the fruit bodies of Fomitopsis pinicola, with their structures established primarily by NMR experiments and chemical methods. To identify the chemical constituents of the fruiting bodies of F. pinicola, researchers isolated a novel lanostane triterpene glycoside named fomitoside K from its methanolic extract.

A chemical investigation on the fruiting bodies of Fomitopsis pinicola led to the isolation and identification of 28 lanostane triterpenoids, including 11 new compounds and 17 known analogues.

Specific named triterpenoids identified from F. pinicola include fomitopinic acids and fomitosides. In a study published by Yoshikawa et al., fomitopinic acids and fomitosides were found to inhibit cyclooxygenase (COX) 1 and 2 activity.

Polysaccharides

Polysaccharides are the principal constituents of the fruiting body of F. pinicola. These include both endo- and exopolysaccharides. The fruiting bodies of fungi from the genus Fomitopsis are rich in biologically active substances with significant medicinal potential, including various enzymes, steroids, triterpenes, and both endopolysaccharides and exopolysaccharides.

Ergosterol and Sterol Derivatives

N-hexane and methanol extracts of F. pinicola contain ergosterol and ergosterol derivatives. Ergosterol may be one of the main constituents of the chloroform extract (FPKc), occupying about 10.5% of its composition based on HPLC calibration.

Phenolic Compounds and Other Constituents

Major chemical constituents of the mushroom also include steroids, alkaloids, coumarins, phenols, tannins, saponins, and carbohydrates. Gallic acid is among the phenolic compounds detected in F. pinicola extracts. Although many of the compounds detected in F. pinicola have not been assessed in isolation, some have been isolated from other species and found to have anti-cancer properties, e.g., gallic acid.

4. Established and Proposed Mechanisms of Action

COX Inhibition (Anti-Inflammatory Mechanism)

Two new lanostane triterpenoids and 10 new lanostane triterpene glycosides have been isolated from the fruit bodies of Fomitopsis pinicola, and their biological activity against COX-1 and COX-2 was investigated. Studies from Yoshikawa and colleagues demonstrated inhibitory activity of these compounds against both cyclooxygenase isoforms, providing a molecular basis for the anti-inflammatory activity traditionally attributed to the mushroom. In a cyclooxygenase activity assay using a Kashmir collection of F. pinicola, the ethyl acetate extract inhibited COX activity by 55.85%.

Antimicrobial Mechanisms

The steroids, lanostane triterpenoids, and ergostane contained in F. pinicola have strong antimicrobial properties. Phenolic compounds are known to disrupt quorum sensing in bacterial biofilms, while triterpenoids can destabilize biofilm matrices. Synergistic interactions with antibiotics led to fractional inhibitory concentration (FIC) indices ≤ 0.5; the extract significantly inhibited biofilm formation and eradicated already formed biofilms; and sub-MIC concentrations reduced quorum sensing by 85.01%, inhibited efflux pump activity, and down-regulated virulence-associated genes.

Antidiabetic Mechanisms

The polysaccharide extract (FPP) derived from F. pinicola was observed to lower fasting blood glucose levels while promoting increased body weight, and FPP displayed a restorative impact on insulin levels in the bloodstream. Moreover, FPP demonstrated a noteworthy influence on lipid metabolism by reducing total cholesterol, triacylglycerol, and low-density lipoprotein cholesterol levels while elevating high-density lipoprotein cholesterol levels. A chemical investigation on the fruiting bodies of Fomitopsis pinicola led to the isolation of 28 lanostane triterpenoids, which were evaluated for PTP1B (protein tyrosine phosphatase 1B) inhibitory and glucose-uptake stimulatory activities. PTP1B is a validated target for type 2 diabetes drug development because its inhibition enhances insulin signaling.

Pro-Apoptotic and Anticancer Mechanisms

Wound healing and transwell assay indicated that the chloroform extract of F. pinicola (FPKc) could inhibit the migration of SW-480 (colorectal cancer) cells, and FPKc also dramatically decreased matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) expression. Annexin V–FITC/PI staining, nuclear Hoechst 33342 staining and DNA fragmentation analysis revealed that FPKc and ergosterol could induce SW-480 cell apoptosis.

Hepatoprotective Mechanisms

The protective effect of F. pinicola mycelia polysaccharides (FPMPS) against alcohol-induced liver injury was assessed using serum biochemical indices and hepatic and cecal morphology. The potential mechanisms of action of FPMPS against acute alcohol-induced liver injury were investigated using gut microbiota and transcriptome analysis. The results showed that FPMPS modulated alcohol metabolism, restored serum lipid levels, and maintained hepatic and cecal morphology. FPMPS ameliorated gut microbial disorders caused by alcohol to protect the liver.

5. Scientific Evidence by Area of Use

5.1 Anticancer and Antitumor Activity

Evidence level: Predominantly in vitro and limited animal studies; no human clinical trials.

In a mini-review of the anti-cancer characteristics of F. pinicola extracts, in vitro experiments revealed the pro-apoptotic, anti-oxidant and anti-inflammatory properties of extracts, whilst two of three in vivo studies reported an inhibition of tumour growth and prolonged survival.

Although F. pinicola has been used as a medicinal fungus for centuries and consumed as a health food supplement, to date the results from only three in vivo studies investigating anti-cancer properties have been published. Further studies, using comprehensively identified specimens, are required to fully elucidate the anti-cancer properties of F. pinicola extracts.

In human colorectal cancer cell lines (SW-480), with 240 µg/ml FPKc treatment, SW-480 cells showed 65.20 ± 2.34% viability loss after 48 hours. The investigators proposed that FPKc might selectively damage some human colon cancer cells while having less effect on non-malignant normal cells, and that ergosterol may play a significant role when FPKc exerts its antitumor function.

Regarding in vivo (animal) anticancer work, one key study produced a negative result: The anti-tumour effect of the F. pinicola extract was tested in a xenograft immune-compromised Rag-1 mouse model using an alcoholic extract. There were no observable differences in tumor growth between treated and non-treated groups. The bioactive components were not detected in the mouse plasma or the tumor site. The investigators concluded the extract was poorly absorbed, likely due to the timing of treatment, dosage levels and modifications made to the extract where the alcohol-based solvent was replaced with water. This result highlights that bioavailability and solvent selection are critical variables in F. pinicola research.

Seven lanostane-type triterpenes isolated from F. pinicola and F. officinalis showed significant antitumor activity, particularly in MCF-7 breast cancer cells. Compounds 2 and 4 effectively suppressed tumor growth in mice, influencing VEGF and cytokine expression. Acetyl or carbonyl at C-3 and hydroxy at C-15 enhanced their antitumor effects.

An ethanolic extract of F. pinicola displayed selective cytotoxicity on HT-29 cancer cells, showing strong inhibition, while normal Vero cells were spared.

5.2 Antimicrobial Activity

Evidence level: In vitro laboratory studies; no human clinical trials.

A study of antimicrobial activity (AMA) of 14 genetically identified dikaryotic strains of red-belted medicinal polypore Fomitopsis pinicola isolated from Betula sp. and other deciduous trees, as well as conifers, demonstrated that cultural broth samples obtained from 21-day static culture demonstrated higher antifungal activity with fungicidic and fungistatic effects against dermatophytes and more than 50% growth inhibition for Penicillium spp. compared with mycelial extracts. Both cultural broth and mycelial extract samples of F. pinicola also showed antibacterial activity against test bacteria.

Ethanol, ethyl acetate, and methanol extracts of F. pinicola show inhibitory effects on S. aureus strains as well as on Gram-negative species such as Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.

A 2025 study specifically examined activity against methicillin-resistant Staphylococcus aureus (MRSA). This study investigated the antimicrobial, antibiofilm, and anti-quorum sensing activity of Fomitopsis pinicola against MRSA strains and its potential to improve the efficacy of conventional antibiotics and exert selective cytotoxic effects on cancer cells. Ethanolic extracts were analyzed for antibacterial activity by MIC and time-kill assays. Synergistic interactions with antibiotics were quantified using checkerboard assays. Antibiofilm activity was analyzed on polystyrene and stainless-steel surfaces.

The antimicrobial potential of a newly isolated Bulgarian fungal strain demonstrated notable antimicrobial effects against all tested bacterial strains, especially the aqueous extract against Escherichia coli and the hexane extract against Salmonella enteritidis.

5.3 Antidiabetic and Metabolic Effects

Evidence level: Animal studies and in vitro; no human clinical trials identified.

Aqueous and alkali extracts of F. pinicola showed significant antihyperglycemic effects in diabetic rats in vivo. A hot water extract obtained from fruiting bodies of the fungus significantly reduced serum glucose and lipid levels in blood, suggesting pharmacological potential in preventing and treating atherosclerosis.

Fomitopsis pinicola extract effectively lowered blood glucose levels by 77% after 20 days, increasing HDL cholesterol by 73% and decreasing LDL cholesterol by 76% (in animal studies). This suggests its potential for atherosclerosis prevention and treatment, though the investigators noted more research is needed to understand the mechanisms involved.

In addition to polysaccharide-based mechanisms, a chemical investigation on the fruiting bodies of Fomitopsis pinicola led to the isolation and identification of 28 lanostane triterpenoids, which were evaluated for PTP1B inhibitory and glucose-uptake stimulatory activities.

5.4 Antioxidant Activity

Evidence level: In vitro and some animal studies; no human clinical trials identified.

F. pinicola has a wide range of therapeutic activity that includes antioxidant action, and a number of studies have confirmed the significant antioxidant activity of F. pinicola fruiting bodies. Fomitopsis pinicola extracts possess significant anti-oxidant and anti-tumor activities comparable to conventional extracts.

Both ethyl acetate and ethanolic extracts from a Kashmir collection lowered ethanol-induced liver lipid peroxidation in mice by nearly 60%.

Solid-state fermentation has been reported to enhance the antioxidant capacity of F. pinicola by 5.7 times, improving the nutritional value of wheat bran.

5.5 Anti-Inflammatory Activity

Evidence level: In vitro and animal studies; no human clinical trials identified.

Ethyl acetate extract of F. pinicola inhibited carrageenan-induced leukocyte infiltration into the peritoneal cavity of mice. Anti-inflammatory activity against croton oil-induced skin inflammation showed that topical application of 20 mg of ethyl acetate extract reduced skin inflammation and leukocyte infiltration. The extract also lowered lipid peroxidation resulting from croton oil application by almost 60%.

5.6 Hepatoprotective Activity

Evidence level: Animal study; no human clinical trials identified.

Fomitopsis pinicola is a medicinal fungus with anti-cancer, anti-inflammatory, anti-diabetic, and anti-obesity properties. The protective effect of F. pinicola mycelia polysaccharides (FPMPS) against alcohol-induced injury was assessed using serum biochemical indices and hepatic and cecal morphology. The potential mechanisms of action of FPMPS against acute alcohol-induced liver injury were investigated using gut microbiota and transcriptome analysis. The results showed that FPMPS modulated alcohol metabolism, restored serum lipid levels, and maintained hepatic and cecal morphology. FPMPS ameliorated gut microbial disorders caused by alcohol to protect the liver. It has also been found that F. pinicola extract is a powerful tool for the prevention and therapy of injured liver and kidney cells in animal models.

5.7 Activity Against Ulcerative Colitis

Evidence level: Animal study; no human clinical trials identified.

The chloroform extract of Fomitopsis pinicola (FPKc) can protect mice from dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) injury. This investigation used a mouse model of induced colitis and represents a preliminary preclinical finding.

5.8 Immunomodulatory Activity

Evidence level: Preliminary; in vitro and animal data.

Fomitopsis pinicola has been intensively studied because it has the function of dispelling wind-evil and dampness in traditional frameworks, and has demonstrated anti-tumor, antifungal, antioxidant, immunomodulation, and neuroprotective activities in preclinical research. Recent research has increasingly focused on the wide array of bioactive compounds produced by fungi of the Basidiomycota division, including polysaccharides, glycoproteins, and triterpenoids. These compounds have demonstrated notable pharmacological properties, particularly antimicrobial, antitumor, and immunomodulatory activities.

6. Body Systems and Health Areas of Association

• Metabolic/Endocrine System: The polysaccharide extract FPP was observed to lower fasting blood glucose levels and displayed a restorative impact on insulin levels in the bloodstream.
• Cardiovascular System: FPP demonstrated a noteworthy influence on lipid metabolism by reducing total cholesterol, triacylglycerol, and low-density lipoprotein cholesterol levels while elevating high-density lipoprotein cholesterol levels.
• Immune System: Polysaccharides and glycoproteins are implicated in immunomodulatory activity in preclinical models.
• Gastrointestinal System: Animal studies suggest protective effects against ulcerative colitis and alcohol-mediated gut microbiota disruption. Modern herbalists have utilized its extracts for gastrointestinal health.
• Hepatic System: The fungus has a wide range of therapeutic activity, including hepatoprotective action.
• Dermatological/Wound Healing: Historically used as a topical agent; topical application of 20 mg of ethyl acetate extract reduced skin inflammation and leukocyte infiltration in animal models.
• Oncological: In vitro experiments revealed the pro-apoptotic, anti-oxidant and anti-inflammatory properties of extracts, whilst two of three in vivo studies reported an inhibition of tumour growth and prolonged survival.
• Infectious Disease / Antimicrobial: Broad-spectrum activity demonstrated in vitro against bacteria and fungi, including MRSA and dermatophytes.

7. Dosage Forms and Dosages Reported in Studies

No standardized or universally agreed-upon therapeutic dosage for human use has been established for F. pinicola, as no controlled human clinical trials have been completed. The following dosages are reported strictly as used in the cited preclinical studies or commercial preparations:

• In vitro studies indicated a 51.2% tumor prevention rate against sarcoma 180 with 30 mg daily dosage (in animal assay).
• In a cell culture assay, 240 µg/ml FPKc (chloroform extract) produced 65.20 ± 2.34% viability loss in SW-480 colorectal cancer cells after 48 hours.
• A registered homeopathic oral drop preparation (Pleo Pin) specifies a dosage of 5–10 drops once daily, before mealtime.
• A registered homeopathic capsule preparation specifies 1–3 capsules daily, either before breakfast or at bedtime.

Investigators in the xenograft mouse study noted that fractionation combined with tissue culture studies showed the majority of the cell proliferative inhibitory activity to be in the hydrophobic (organic) fraction. The use of a hydrophilic-based solvent may have reduced the solubility of the active component in the GI tract of the mice, limiting absorption and promoting excretion in the feces. Dissolving the extract in an organic-based solvent such as corn or palm oil could potentially enhance absorption and increase bioavailability of the active compounds without inducing toxicity.

8. Safety Considerations and Interactions

General Safety Profile

This mushroom is believed to be non-toxic, and also has many clinical effects. F. pinicola as a nontoxic natural product has attracted more and more attention from scholars, and its extracts have been reported to have anti-inflammatory, anti-microbial, anti-fungal and anticancer effects.

Absence of Human Safety Data

Human clinical trials on Fomitopsis pinicola remain limited. While some early-stage research highlights potential health-promoting effects, robust evidence from large-scale human studies is still needed to confirm its efficacy and safety as a nutritional ingredient.

Bioavailability and Solvent Considerations

A key finding from the in vivo xenograft mouse study is that extract preparation method critically affects bioavailability and tolerability. The original F. pinicola extract was an alcoholic extract containing approximately 50% ethanol. Due to mice being extremely sensitive to ethanol, the alcoholic content was removed and the extract was resuspended in water as a 5% dextrose solution. The removal of ethanol increased the dosage the mice could tolerate without inducing alcohol toxicity.

Regulatory Status in Homeopathic Preparations

Homeopathic products based on Fomitopsis pinicola registered on DailyMed (NLM) carry the disclaimer that such homeopathic products have not been evaluated by the Food and Drug Administration for safety or efficacy, and the FDA is not aware of scientific evidence to support homeopathy as effective.

Selective Cytotoxicity: Cancer vs. Normal Cells

HEK-293 normal cells showed much lower injury compared to SW-480 cancer cells (p < 0.01) when treated with FPKc chloroform extract, suggesting a degree of tumor cell selectivity. Similarly, the extract displayed selective cytotoxicity on HT-29 cancer cells, showing strong inhibition, while normal Vero cells were spared. These are in vitro observations and do not constitute safety evidence in humans.

Taxonomic Identity as a Safety and Reproducibility Issue

Researchers and consumers should note the taxonomic species complex problem: recent phylogenetic studies indicate that the true F. pinicola is restricted to Eurasia on hosts like Picea and Pinus, while morphologically similar taxa in North America and East Asia represent distinct species. This means commercial products labeled as F. pinicola sourced from North America may not represent the species on which European and Asian traditional use and the majority of published research is based, raising uncertainty about both efficacy and safety of such products.

Absence of Drug Interaction Data

No peer-reviewed human studies evaluating drug-drug or drug-supplement interactions for F. pinicola preparations were identified in the published literature as of this writing. Its antidiabetic properties in animal models suggest a theoretical additive interaction with hypoglycemic agents that would require investigation in humans.

References

• Frontiers in Cellular and Infection Microbiology (2025): The bioactive compounds, beneficial medicinal properties, and biotechnological prospects of Fomitopsis: a comprehensive overview
• PubMed / Int J Med Mushrooms (2024): Antimicrobial Activity of Different Collections of Medicinal Polypore Fungus Fomitopsis pinicola (Agaricomycetes)
• PMC (2025): Molecular Identification, Mycelial Growth Kinetics, and Antimicrobial Potential of Newly Isolated Medicinal Mushroom Fomitopsis pinicola from Bulgaria
• PMC / Food Science & Nutrition (2025): The Dual Role of the Medicinal Mushroom Fomitopsis pinicola in Inhibiting Biofilm and Reducing Antibiotic Resistance of Methicillin-Resistant Staphylococcus aureus
• PMC / Nutrients (2020): Characterisation of Extracts and Anti-Cancer Activities of Fomitopsis pinicola
• PMC / PLoS ONE (2014): Investigating Migration Inhibition and Apoptotic Effects of Fomitopsis pinicola Chloroform Extract on Human Colorectal Cancer SW-480 Cells
• Nutrition and Cancer (2019): Anticancer Characteristics of Fomitopsis pinicola Extract in a Xenograft Mouse Model — a Preliminary Study
• PMC / Fungal Biology and Biotechnology (2024): Enhancement of antioxidant activity and total phenolic content of Fomitopsis pinicola mycelium extract
• Journal of Natural Products (2005): Lanostane Triterpenoids and Triterpene Glycosides from the Fruit Body of Fomitopsis pinicola and Their Inhibitory Activity against COX-1 and COX-2
• Journal of Agricultural and Food Chemistry (2020): Lanostane Triterpenoids with PTP1B Inhibitory and Glucose-Uptake Stimulatory Activities from Mushroom Fomitopsis pinicola Collected in North America
• ScienceDirect Topics: Fomitopsis — overview (Phytomedicine, 2020)
• Process Biochemistry (2008): Properties and biological functions of polysaccharides and ethanolic extracts isolated from medicinal fungus, Fomitopsis pinicola
• PMC / Frontiers in Microbiology (2021): Taxonomy and Phylogeny of the Fomitopsis pinicola Complex With Descriptions of Six New Species From East Asia
• Folia Microbiologica (2026): The antimicrobial potential of Fomitopsis pinicola across multiple applications
• International Journal of Advanced Research (2018): Antioxidant and Anti-inflammatory Activities of Bioactive Extracts of a Polypore Mushroom, Fomitopsis pinicola, from Kashmir
• Authorea (2023): The protective effect and potential mechanism analysis of Fomitopsis pinicola mycelia polysaccharides (FPMPS) on acute alcoholic liver injury in mice
• Annals of Translational Medicine (2022): The beneficial effects of Fomitopsis pinicola chloroform extract on a dextran sulfate sodium-induced ulcerative colitis mice model
• DailyMed (NLM): PLEO PIN — Fomitopsis pinicola solution/drops labeling
• DailyMed (NLM): PLEO PIN — Fomitopsis pinicola capsule labeling
• ResearchGate / Korean Journal of Chemical Engineering (2009): Effect of Fomitopsis pinicola extract on blood glucose and lipid metabolism in diabetic rats
• ScienceDirect: Fungi in folk medicine (European Medicinal Polypores — a Modern View on Traditional Uses, Journal of Ethnopharmacology, 2014)